BRCA Biomarkers
Genetic Testing Challenges in Oncology: BRCA1 Variant Downgraded After Risk-Reducing Surgery
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
Clovis Oncology's Q2 Rubraca Sales Dip 8 Percent
The company attributed lower revenues to the negative impact from the COVID-19 pandemic but highlighted its ongoing R&D efforts to expand the drug's indication.
Genetic Testing Challenges in Oncology: Consumer Genomics Reveals More Than Fun Traits
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
AstraZeneca Q2 Revenues Increase 31 Percent
The company reported revenues of $8.22 billion, largely driven by sales of its COVID-19 vaccine, but also due to strong performance of its oncology segment.
A recent JAMA study underscores racial disparities in genetic test access, which UPenn's Basser Center aims to address through its Black &Â BRCAÂ initiative.